• Health & Medicine

Three breast cancer relapse tests recommended for NHS use

Three tests designed to predict if breast cancer will come back after treatment have been recommended for use on the NHS. Three tests designed to predict if breast cancer will come back after treatment have been recommended for use on the NHS.

20 December 2018

• Health & Medicine

Targeted drug not approved for certain lymphoma patients on the NHS

People with a certain type of lymphoma will not be able to receive a targeted cancer drug on the NHS in England. People with a certain type of lymphoma will not be able to receive a targeted cancer drug on the NHS in England.

20 December 2018

• Health & Medicine

Too soon to say cervical cancer DNA test will ‘revolutionise screening’

A new cervical cancer test is big news this week. The science behind the headlines is exciting, but it's a long way from being used in cervical screening. A new cervical cancer test is big news this week. The science behind the headlines is exciting, but it's a long way from being used in cervical screening.

19 December 2018

• Science & Technology

Immune cells cast DNA ‘webs’ that may help ovarian cancer spread

Scientists have discovered that immune cells play a role in helping ovarian cancer cells to spread in mice. Scientists have discovered that immune cells play a role in helping ovarian cancer cells to spread in mice.

19 December 2018

• Health & Medicine

Specialist MRI scans recommended to help diagnose prostate cancer on NHS

A type of specialist MRI scan has been recommended as one of the first tests for diagnosing people with suspected prostate cancer A type of specialist MRI scan has been recommended as one of the first tests for diagnosing people with suspected prostate cancer

13 December 2018

• Health & Medicine

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England. People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

13 December 2018

• For Supporters

Liverpool scientists awarded £2.17 million by Cancer Research UK to spot pancreatic cancer early

Scientists in Liverpool have been awarded £2.17 million by Cancer Research UK to develop ways to spot pancreatic cancer earlier. Scientists in Liverpool have been awarded £2.17 million by Cancer Research UK to develop ways to spot pancreatic cancer earlier.

12 December 2018

• Science & Technology
• Health & Medicine

Lung cancer screening part 2: research into detection technology could lead to better tests

Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening. Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening.

6 December 2018

• Health & Medicine

Lung cancer screening part 1: the benefits and harms according to clinical trials

Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms. Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms.

4 December 2018

• Health & Medicine

Women reveal reasons they reject a preventive treatment for breast cancer

Only around a fifth of women at higher risk of developing breast cancer think they need to take a drug proven to help prevent the disease. Only around a fifth of women at higher risk of developing breast cancer think they need to take a drug proven to help prevent the disease.

3 December 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with advanced skin cancer after surgery

An immunotherapy drug will be made available to some patients with advanced melanoma skin cancer on the NHS in England. An immunotherapy drug will be made available to some patients with advanced melanoma skin cancer on the NHS in England.

30 November 2018

• Science & Technology

Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb join forces to map out lung cancer immunology

This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments. This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments.

30 November 2018